At day 21 there was regional heterogeneity in Ki67 with higher levels at the peripheral/leading edge of the tumor and lower levels in the intermediate zone and avascular tumor center and regions of geographic necrosis (S1 Fig). This evidence concerns the gene MKI67 and neoplasm.